Cancer Research and Treatment

Drug-Induced Peripheral Neuropathy: Diagnosis and Management

Diala Merheb, Georgette Dib, Maroun Bou Zerdan, Clara El Nakib, Saada Alame, Hazem I. Assi

Current Cancer Drug Targets.2022; 22(1): 49. CrossRef

Treatment Outcome and Safety of the TCX Regimen for Advanced Gastric Cancer: A Prospective Cohort Study

Hieu Trong Nguyen, Kien Hung Do, Nguyen Ba Le, Thang Tran

Cancer Management and Research.2022; Volume 14: 2825. CrossRef

Role for Drug Transporters in Chemotherapy‐Induced Peripheral Neuropathy

Tore B. Stage, Shuiying Hu, Alex Sparreboom, Deanna L. Kroetz

Clinical and Translational Science.2021; 14(2): 460. CrossRef

Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease

Daniel V.T. Catenacci, Stephanie Moya, Samantha Lomnicki, Leah M. Chase, Bryan F. Peterson, Natalie Reizine, Lindsay Alpert, Namrata Setia, Shu-Yuan Xiao, John Hart, Uzma D. Siddiqui, D. Kyle Hogarth, Oliver S. Eng, Kiran Turaga, Kevin Roggin, Mitchell C.

Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy

Giulia Fumagalli, Laura Monza, Guido Cavaletti, Roberta Rigolio, Cristina Meregalli

Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems

Nathan P. Staff, Jill C. Fehrenbacher, Martial Caillaud, M. Imad Damaj, Rosalind A. Segal, Sandra Rieger

Experimental Neurology.2020; 324: 113121. CrossRef

Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma

Yoko Tomita, Max Moldovan, Rachael Chang Lee, Amy HC Hsieh, Amanda Townsend, Timothy Price

Cochrane Database of Systematic Reviews.2020;[Epub] CrossRef

Paclitaxel, 5-fluorouracil, and leucovorin combination chemotherapy as first-line treatment in patients with advanced gastric cancer

Wan-Cai Que, Yan-Fang Huang, Xiao-Yan Lin, Yan-Qin Lan, Xin-Yan Gao, Xin-Li Wang, Ri-Ping Wu, Bin Du, Xiao-Bin Huang, Hong-qiang Qiu, Dong-Ta Zhong

Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer

Chan Kim, Hong Jae Chon, Joo Hoon Kim, Minkyu Jung, Chung Mo Nam, Hyo Song Kim, Beodeul Kang, Hyun Cheol Chung, Sun Young Rha

European Journal of Cancer.2019; 112: 20. CrossRef

Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study

Peter C Thuss-Patience, Manish A Shah, Atsushi Ohtsu, Eric Van Cutsem, Jaffer A Ajani, Hugo Castro, Wasat Mansoor, Hyun Cheol Chung, Gyorgy Bodoky, Kohei Shitara, Gail D Lewis Phillips, Tina van der Horst, Marie-Laurence Harle-Yge, Betsy L Althaus, Yoon-K

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy

Frontiers in Molecular Neuroscience.2017;[Epub] CrossRef

Identifying therapeutic targets in gastric cancer: the current status and future direction

Acta Biochimica et Biophysica Sinica.2016; 48(1): 90. CrossRef

Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy

Paclitaxel combined with oxaliplatin as first-line chemotherapy for locally advanced or metastatic gastric cancer

Chunmei Shi, Qiang Chen, Songfei Shen, Riping Wu, Baoyu Yang, Qing Liu, Qian Xu

Expert Review of Anticancer Therapy.2015; 15(5): 595. CrossRef

Corosolic acid enhances 5-fluorouracil-induced apoptosis against SNU-620 human gastric carcinoma cells by inhibition of mammalian target of rapamycin

HYUN SU LEE, JUN BEOM PARK, MYUNG SUN LEE, EUN YOUNG CHA, JI YEON KIM, JI YOUNG SUL

Molecular Medicine Reports.2015; 12(3): 4782. CrossRef

Paclitaxel-based regimens as first-line treatment in advanced gastric cancer

Zengqing Guo, Xiaojie Wang, Rongbo Lin, Ling Chen, Nanfeng Fan, Yu Chen, Jinyuan Lin, Jiami Yu

Journal of Chemotherapy.2015; 27(2): 94. CrossRef

A phase 2 study of fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as a salvage treatment in patients with refractory or relapsed advanced gastric cancer

Rongbo Lin, Nanfeng Fan, Guangfeng Wu, Ying Chen, Zengqing Guo, Xiaojie Wang, Feng Jin, Ling Chen, Jie Liu

Journal of Chemotherapy.2015; 27(1): 52. CrossRef

Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer

MEIQIN YUAN, YUNSHAN YANG, WANGXIA LV, ZHENGBO SONG, HAIJUN ZHONG

Chemotherapy-induced peripheral neurotoxicity (CIPN): An update

Andreas A. Argyriou, Jordi Bruna, Paola Marmiroli, Guido Cavaletti

Critical Reviews in Oncology/Hematology.2012; 82(1): 51. CrossRef

Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention

Successful Treatment of a Patient with HER2-Positive Metastatic Gastric Cancer with Third-Line Combination Therapy with Irinotecan, 5-Fluorouracil, Leucovorin and Trastuzumab (FOLFIRI-T)

Florian Weissinger, Marc Reymond, Klaus Dumke, Martin Krüger

RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase

Kyung-Hun Lee, Hyung-Seok Hur, Seock-Ah Im, Juhee Lee, Hwang-Phill Kim, Young-Kwang Yoon, Sae-Won Han, Sang-Hyun Song, Do-Youn Oh, Tae-You Kim, Yung-Jue Bang